Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EP300 | Q09472 | 1/20 | 0.53 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.50 |
| ▸ | TSHR | P16473 | 2/20 | 0.48 |
| ▸ | LMNA | P02545 | 2/20 | 0.47 |
| ▸ | TERT | O14746 | 3/20 | 0.47 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.47 |
| ▸ | PPARG | P37231 | 3/20 | 0.47 |
| ▸ | PPARD | Q03181 | 3/20 | 0.47 |
| ▸ | PPARA | Q07869 | 3/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.47 |
| ▸ | MAPT | P10636 | 2/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.47 |
| ▸ | BLM | P54132 | 2/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.47 |
| ▸ | FABP4 | P15090 | 2/20 | 0.47 |
| ▸ | FAAH | O00519 | 2/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | GMNN | O75496 | 1/20 | 0.47 |
| ▸ | USP2 | O75604 | 1/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11879010 | 1.00 | EP300 (0.53) | EP300TDP1TSHRLMNATERT | |
| SCHEMBL9515085 | 1.00 | EP300 (0.53) | EP300TDP1TSHRLMNATERT | |
| SCHEMBL18339363 | 1.00 | EP300 (0.53) | EP300TDP1TSHRLMNATERT | |
| SCHEMBL10384756 | 1.00 | EP300 (0.53) | EP300TDP1TSHRLMNATERT | |
| SCHEMBL9515083 | 1.00 | EP300 (0.53) | EP300TDP1TSHRLMNATERT | |
| SCHEMBL10384232 | 1.00 | EP300 (0.53) | EP300TDP1TSHRLMNATERT | |
| SCHEMBL10384755 | 1.00 | EP300 (0.53) | EP300TDP1TSHRLMNATERT | |
| SCHEMBL15316248 | 1.00 | EP300 (0.53) | EP300TDP1TSHRLMNATERT | |
| SCHEMBL20917244 | 1.00 | EP300 (0.53) | EP300TDP1TSHRLMNATERT | |
| SCHEMBL10384235 | 1.00 | EP300 (0.53) | EP300TDP1TSHRLMNATERT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240308946-A1 | PRODUCTION OF LIGNIN DERIVED RENEWABLE LUBRICANTS | UNIVERSITY OF DELAWARE (US) | 2024-09-19 | — | — | US | disclosed |
| EP-4381031-A1 | PRODUCTION OF LIGNIN DERIVED RENEWABLE LUBRICANTS | University of Delaware (US) | 2024-06-12 | — | — | EP | disclosed |
| CN-111315714-B | Etherification process | 英国石油有限公司 | 2023-10-27 | — | — | CN | disclosed |
| WO-2023015037-A1 | PRODUCTION OF LIGNIN DERIVED RENEWABLE LUBRICANTS | UNIVERSITY OF DELAWARE (US) | 2023-02-09 | — | — | WO | disclosed |
| US-11472759-B2 | Etherification process | BP P.L.C. (GB) | 2022-10-18 | — | — | US | disclosed |
| US-20210363084-A1 | Etherification Process | BP P.L.C. (GB) | 2021-11-25 | — | — | US | disclosed |
| EP-3697749-B1 | ETHERIFICATION PROCESS | BP PLC (GB) | 2021-09-15 | — | — | EP | disclosed |
| EP-3697749-A1 | ETHERIFICATION PROCESS | BP P.L.C. (GB) | 2020-08-26 | — | — | EP | disclosed |
| WO-2019077146-A1 | ETHERIFICATION PROCESS | BP P.L.C. (GB) | 2019-04-25 | — | — | WO | disclosed |
| WO-2003095407-A2 | 2,4-DIALKYL-BRANCHED ALDEHYDES AND DERIVATIVES PRODUCED THEREFROM | SASOL GERMANY GMBH (DE) | 2003-11-20 | — | — | WO | disclosed |
| US-3948991-A | Cyclic aldol condensation process and catalyst regeneration procedure | GULF RESEARCH & DEVELOPMENT COMPANY (US) | 1976-04-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210363084-A1 | Etherification Process | DHCR24, CYP8B1, ECH1 | EP300 2996/4885TDP1 2647/4885TSHR 3454/4885 |
| US-11472759-B2 | Etherification process | DHCR24, CYP8B1, ECH1 | EP300 2996/4885TDP1 2647/4885TSHR 3454/4885 |
| US-20240308946-A1 | PRODUCTION OF LIGNIN DERIVED RENEWABLE LUBRICANTS | LARS1, DCXR, LIG1 | EP300 2068/4885TDP1 585/4885TSHR 4233/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.